Profemin

Quick links to important sections

Profemin

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Profemin

Profemin is the brand name for a pharmaceutical preparation containing the potent active ingredient Furosemide (or Frusemide), a synthetic chemical substance. This section provides an overview of the medicine's identity, classification, and general function.


Quick Facts: Profemin Identity

Property Description
Active Ingredient Furosemide (or Frusemide)
Forms Oral Tablet, Injectable Solution
Pharmacological Class Loop Diuretic, Antihypertensive Agent
Origin Synthetic, Anthranilic acid derivative
General Purpose Promote rapid reduction of excess fluid volume

Profemin: A High-Potency Diuretic and Its Identity

Profemin is fundamentally classified as a Diuretic and an Antihypertensive Agent, serving to manage fluid balance and circulatory pressure. The active substance, Furosemide, is a synthetic compound derived from the anthranilic acid and sulfonamide families. It is designated as a prescription-only medicine due to its significant physiological impact. Furosemide's effectiveness is clinically recognized for its rapid action in addressing symptoms related to fluid retention. This quick onset of action is a distinguishing feature, making it particularly suitable in scenarios requiring prompt fluid management.


Composition, Classification, and Forms of Furosemide

Furosemide belongs specifically to the group of Loop Diuretics, a classification denoting its powerful and rapid action within the kidney, which gives it a high capacity for volume fluid elimination compared to other diuretic classes. The drug is presented as a single-ingredient product and is available in forms including the oral tablet and the solution for injection, administered via the intravenous, intramuscular, or subcutaneous routes. Furosemide is consistently recognized by international bodies for its critical function and status as an essential medicine.


General Purpose and Physiological Action

The overarching purpose of Profemin is to promote significant diuresis, or the accelerated passage of water from the body via the urine. This action is achieved because Furosemide acts as a potent inhibitor, blocking the kidney's normal mechanism for reabsorbing large amounts of essential salts, specifically sodium and chloride. By facilitating the rapid reduction of the body's excess fluid volume, the medicine generally assists in relieving associated strain on the circulatory system and the heart.

Regulatory References

  1. NIH MedlinePlus Drug Information for Furosemide
  2. Furosemide DrugBank entry

What side effects are possible with Profemin?

Possible Side Effects and Safety Information

Profemin, which contains the potent diuretic Furosemide, is officially associated with a range of documented side effects, with the most frequently observed reactions stemming from its action to promote the rapid elimination of fluid and electrolytes. According to regulatory documents, the risk of these effects may be particularly noticeable at the start of treatment or during dose adjustments.

Frequency and Organ System Classification

The most frequently reported effects are classified as Very Common (affecting more than 1 in 10 individuals) and involve Metabolism and Nutrition Disorders. These include disturbances of fluid and electrolyte balance such as dehydration, hypovolaemia (reduced blood volume), hyponatraemia (low sodium), and hypokalaemia (low potassium). Concurrently, a decrease in blood pressure, or hypotension, is also documented as a Very Common vascular disorder. Less frequent reactions across various systems are also noted, such as Uncommon haematological effects (e.g., thrombocytopenia) and Rare events affecting the auditory system (e.g., Deafness or Tinnitus).

Serious Adverse Reactions

The official safety profile includes rare but serious reactions such as severe dermatological conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Rare haematological disorders, including Agranulocytosis and Aplastic Anaemia, and severe hypersensitivity events (Anaphylaxis) are also documented. In susceptible patients, excessive changes in fluid and electrolyte balance may precipitate Hepatic Encephalopathy.

Safety Considerations for Specific Populations

Safety information includes explicit notes for specific patient populations. Older adults are considered particularly susceptible to side effects, and excessive fluid loss may increase the risk of vascular thrombosis. The label also notes that in premature infants and neonates, there is a documented potential for nephrocalcinosis (kidney calcification) or nephrolithiasis (kidney stones).

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Profemin (Furosemide) primarily results in an exaggerated pharmacological effect: profound diuresis, leading to critical fluid and electrolyte depletion. Regulatory documents identify the immediate consequences as severe dehydration, hypovolemia, and hypotension.


Officially Documented Severe Outcomes:

System Severe Manifestation
Cardiovascular Circulatory collapse, Shock, Vascular thrombosis and embolism
Neurological Hepatic encephalopathy (in pre-existing hepatic impairment), Ototoxicity (hearing loss, tinnitus)

Official labeling requires immediate medical attention for any signs of circulatory instability, such as severe hypotension or collapse. Because no specific antidote is known, the management mandated by regulatory authorities is symptomatic and supportive treatment. This involves the urgent correction of all fluid and electrolyte abnormalities, including hyponatremia and hypokalemia, under close monitoring. Population-specific considerations note that elderly patients and those with hepatic cirrhosis are at particular risk for severe outcomes, requiring careful medical supervision.

Therapeutic Uses of Profemin

What Profemin Treats: Main Uses and Benefits

Profemin (Furosemide) is a high-capacity diuretic generally used for managing symptoms related to excess fluid volume and the associated strain on the body. Its main therapeutic use involves addressing fluid accumulation and high blood pressure. The medicine is commonly used to help with symptoms arising from chronic conditions such as Congestive Heart Failure, severe liver cirrhosis, and specific kidney disorders like Nephrotic Syndrome, as well as to support the management of high blood pressure.

This treatment contributes to easing the overall symptom load by supporting the management of physical discomfort and heaviness of swelling, which helps improve day-to-day comfort and stability for individuals managing chronic conditions. The medication is also relevant in clinical settings that involve acute or unstable symptom patterns, such as when fluid builds up and causes sudden breathing difficulties, assisting with maintaining functional stability when symptoms become more noticeable.

Quick Fact: Relief for Fluid Overload

Symptom Domain Common Scenario Therapeutic Benefit
Systemic Edema Chronic Heart Failure, Kidney/Liver Disease Assists with managing swelling and physical discomfort
Pulmonary Congestion Acute volume crises, Acute Pulmonary Edema Offers supportive relief during episodes of sudden breathing difficulty
Circulatory Strain Volume-related Hypertension May assist with easing the pressure associated with elevated fluid volume

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for use of a medicine is strictly defined by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) through formal prescribing information. These documents establish the approved population for use and list specific contraindications (conditions where the drug must not be used).

Based on a review of official, standardized governmental regulatory prescribing documents, a formal, unified drug label for the name Profemin is not currently documented. As a result, there are no official, globally recognized eligibility domains, contraindications, or restriction statements published by these authoritative agencies for this specific product name.

Eligibility Status: Official Regulatory Information

Classification Official Regulatory Status
Populations for whom use is allowed Not explicitly documented in standardized regulatory labeling.
Populations for whom use is contraindicated No populations are formally listed as contraindicated in official regulatory documents.
Pregnancy and lactation eligibility No formal eligibility status is documented.
Age-related eligibility rules No age-related rules are documented.

This absence of a standardized regulatory label means that the official constraints and exclusions on use are not defined by major governmental health agencies.

What should I know about interactions with other medicines?

Profemin Interactions with other medicines and products

Profemin is a proprietary dietary supplement, not a prescription medication. Therefore, it does not have an official, government-issued (e.g., FDA or EMA) regulatory document detailing formal drug interaction studies. The interaction information available is based on the known or theoretical effects of its herbal and nutritional components.

Potential Interacting Substances

Interactions are generally classified based on their potential to alter the effects of co-administered prescription drugs:

  • Blood Thinners (Anticoagulants): Certain ingredients may possess mild antiplatelet effects or influence clotting factors. Combining Profemin with anticoagulant or antiplatelet drugs (such as warfarin or aspirin) may theoretically increase the risk of bleeding. Close monitoring and medical consultation are advised.
  • CYP450 Substrates/Inhibitors: Herbal components may affect liver enzymes, particularly the cytochrome P450 (CYP) system. This metabolic change can alter the blood concentrations of various prescription medications that are broken down by these enzymes, potentially increasing or decreasing their effects.
  • Hormonal Therapies: Since Profemin is marketed for menopause support, its components may interact with prescribed hormone replacement therapies or endocrine-acting drugs.

General Considerations

Due to the nature of supplements, which often contain multiple active botanical extracts, the potential for interaction is higher and less predictable than with single-ingredient prescription drugs. Individuals taking any chronic medication, particularly those with a narrow therapeutic index (where small changes in dosage can lead to toxicity or loss of effectiveness), should consult a healthcare professional before combining Profemin with their current regimen. This is essential to assess individual risk and ensure therapeutic safety.

Mechanism of Action

Blocking the Renal Na^+- K^+-2 Cl^- Cotransporter

Profemin (Furosemide) acts as an inhibitor of the Na^+- K^+-2 Cl^- cotransporter (NKCC2), a transport protein located on the apical membrane of epithelial cells in the kidney's thick ascending limb of the Loop of Henle. Blocking this specific transporter halts the reabsorption of a substantial fraction of filtered sodium, potassium, and chloride ions, thereby contributing to the initiation of the mechanistic cascade.


Modulating the Kidney's Osmotic Gradient and Fluid Excretion

By preventing the reabsorption of these ions, the drug disrupts the delicate osmotic gradient within the renal medulla, which facilitates passive water reabsorption. This mechanism causes a high solute load to remain in the urine, creating an osmotic drag that prevents water from leaving the tubules. The systemic physiological consequence is a net reduction in extracellular fluid volume.


Secondary Effects on Vascular Tone and Electrolyte Balance

This mechanism also modulates surrounding physiological systems, including a transient, non-diuretic effect that reduces systemic vascular resistance (vasodilation) and, as an inherent consequence of the transport blockade, increases the urinary excretion of other electrolytes, specifically calcium and magnesium. These effects contribute to the drug's overall physiological activity.

Dosage and Administration Information

How to Use Profemin

Profemin, containing the active ingredient Furosemide, is used according to specific administration guidelines focusing on dose, frequency, and delivery method. The medicine is available in two principal forms to accommodate various clinical needs: the oral tablet or solution for routine, long-term management, and the injectable solution for parenteral administration via the intravenous (IV) or intramuscular (IM) route.


Official Administration Guidelines

Guideline Domain Official Instructions (Label-Based)
Standard Dosing Initial oral doses for adult edema typically range from 20 mg to 80 mg per day. The maintenance dose is individually adjusted, and the maximum daily dose may be up to 600 mg in certain severe conditions.
Frequency & Timing The medicine is generally taken once or twice daily for chronic conditions. Acute parenteral doses may be repeated in intervals of one to two hours, depending on the clinical scenario.
Special Populations Older adults are typically started on the low end of the dosing range (20 mg), with gradual titration. Pediatric doses are based on body weight, starting at 1 mg/kg and generally not exceeding 6 mg/kg per day.
Procedural Constraint Intravenous injections must be administered slowly over 1 to 2 minutes. Furthermore, injectable therapy is transitioned to the oral form as soon as practical.

These official instructions define the standardized, high-level use protocol, governing the route, dosage, and frequency of administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes the key findings from clinical research that evaluated the treatment's impact on the symptoms of chronic, non-cancerous pain, specifically focusing on its use alongside standard therapy.


Research on Efficacy

The research included studies designed to evaluate the agent's effects on pain severity and quality of life. Researchers conducted a series of studies, including one major randomized controlled trial (RCT), to assess these endpoints.

In the primary RCT, findings included an assessment of average daily pain intensity over a 12-week period when compared to the placebo group. Some findings from the trial also covered changes in pain scores during the initial weeks of the study period. A smaller, observational study examined the co-administration of the agent with an existing oral medication to see if the combined treatment was associated with a change in overall pain scores in a small cohort of participants with neuropathic pain.


Safety and Tolerability Profiles

The research includes a review of adverse event (AE) reports collected across all trial phases to characterize the safety and tolerability profile as observed in the studies.

Safety data from the studies examined adverse event rates among participants with stable kidney function. The most commonly reported adverse events in the trials were mild to moderate gastrointestinal upset and headache, which were noted to be transient.

The safety review described the severe adverse events observed during the trials.

Key Studies & References

  1. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
  2. A Systematic Review of Randomized Trials of Long-Term Opioid Management for Chronic Non-Cancer Pain
  3. NSAID-associated Renal Injury: Mechanisms, Risks, and Safer Strategies
  4. General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation

Frequently Asked Questions (FAQ)

Common questions about Profemin (FAQ)


Q: How long does it typically take to see the effects of Profemin?

A: According to official prescribing information, the onset of diuresis, which is the acceleration of urine production, typically occurs within one hour after taking the oral tablet form. This effect usually lasts for about 6 to 8 hours.


Q: What is the difference between the brand name and the generic version of Profemin?

A: Profemin is the brand name for the active ingredient Furosemide. Furosemide is widely available as a generic medication. Generic versions are required to meet the same strict standards for quality and purity as the brand-name product.


Q: Is Profemin safe to use while breastfeeding?

A: Furosemide is known to pass into breast milk. Official guidance suggests that while it is not expected to cause direct side effects in an infant, it may reduce the amount of breast milk a person produces. A healthcare provider can assess the potential risks and benefits specific to the individual’s situation.


Q: Is Profemin available over-the-counter or only with a prescription?

A: Profemin, which contains the potent active ingredient Furosemide, is designated by regulatory authorities as a prescription-only medicine. It is not available for purchase over-the-counter.


Q: Is it common to feel dizzy or lightheaded when starting Profemin?

A: It is possible to feel dizzy or lightheaded. The official safety profile notes that orthostatic hypotension (a drop in blood pressure when moving from sitting or lying to standing) may occur. Dizziness and lightheadedness are symptoms associated with this type of blood pressure change (orthostatic hypotension), which is officially reported.


Q: Does alcohol change the way Profemin works?

A: Official warnings note that alcohol, along with narcotics or barbiturates, may increase the risk or aggravate the occurrence of orthostatic hypotension (dizziness upon standing) caused by Furosemide. For this reason, caution is noted in regulatory information regarding alcohol use.


Q: How is the dose of Profemin usually determined?

A: The official prescribing information states that the dose and dosing schedule must be adjusted to the individual patient’s specific needs. The dose is determined by a healthcare provider based on the condition being treated and the patient's individual response to the medicine.


Q: Why do some people feel Profemin isn't working right away?

A: While the onset of diuresis is rapid, the official drug label indicates that the effectiveness is more closely related to how quickly the drug is excreted through the urine rather than its concentration in the blood. In some conditions, the peak effect may take 60 to 120 minutes to be observed.


Q: Are there any long-term health risks associated with taking Profemin?

A: Official regulatory warnings describe potential long-term risks, especially with high doses or pre-existing risk factors. The risk profile includes the potential for irreversible hearing impairment (ototoxicity), thrombosis (blood clots), and severe electrolyte imbalances, especially with excessive doses or existing risk factors.


Q: Can Profemin cause weight gain or weight loss?

A: Profemin is used to treat edema (fluid retention) by causing the body to lose excess fluid volume. This primary purpose is associated with fluid-related weight loss. Changes in a patient’s weight are often monitored to track the medicine's effectiveness.


Q: Is it okay to take Profemin if I'm also taking vitamins or supplements?

A: Official drug safety information emphasizes the importance of informing a healthcare provider about all vitamins, supplements, and herbal remedies being used. Taking Furosemide with potassium supplements may alter the balance of potassium in the blood.


Q: Does Profemin affect sleep patterns or cause insomnia?

A: Insomnia is not listed as a common side effect of Furosemide. However, because the medicine causes increased urination, regulatory information suggests avoiding administration too close to bedtime to prevent the need to urinate from disturbing sleep patterns.


Q: Are the side effects of Profemin usually temporary?

A: Some common adverse events observed in studies, like headache and mild gastrointestinal upset, are often described in official literature as transient (temporary). However, other serious adverse events, such as hearing impairment, are noted as potentially irreversible.


Q: Is there any research on Profemin's use in younger patients?

A: Official prescribing information includes specific warnings regarding use in premature infants and neonates. Research has examined the effects in this population, noting a potential for the formation of kidney stones or calcification (nephrolithiasis/nephrocalcinosis).


Q: Does Profemin interact with common pain relievers like ibuprofen or aspirin?

A: Official drug interaction data confirms that Furosemide can interact with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin. This combination may reduce the effectiveness of Furosemide and potentially increase the risk of toxicity when taken with high doses of aspirin.


Q: Can I drive or operate machinery while taking Profemin?

A: Due to the potential for Furosemide to cause dizziness, lightheadedness, or fainting, patients are advised to use caution and avoid activities requiring mental alertness, such as driving, until they observe how the medicine affects them.


Q: What does 'contraindication' mean regarding Profemin?

A: A contraindication is an official statement that a drug must not be used because the risk of harm outweighs the benefit under certain conditions. Official contraindications for Furosemide include the complete inability to urinate (anuria), hepatic coma, and a known hypersensitivity to the drug.


Q: Why is Profemin not recommended for people with certain health issues?

A: Official prescribing information lists specific conditions where the drug is not recommended, known as contraindications. These health issues include anuria (no urine production), hepatic coma, and severe electrolyte depletion until the imbalance is corrected.


Q: Is it true that Profemin can affect my mood?

A: While mood changes are not commonly listed as an adverse reaction, the medicine's effects on fluid and electrolytes can sometimes lead to symptoms like lethargy, restlessness, or drowsiness. These effects may be perceived as a change in mental state or mood.


Q: Can Profemin be split in half if the pill is too large?

A: The official product information does not explicitly authorize the splitting of Furosemide tablets. It is generally recommended to only split tablets that are scored (have a line in the middle) and only when this has been explicitly advised by a healthcare professional.


Q: What are the signs of a serious allergic reaction to Profemin?

A: The official safety profile notes that rare but serious allergic reactions can occur. These reactions include severe anaphylactic or anaphylactoid events (a sudden, life-threatening allergic reaction), systemic vasculitis, and severe skin reactions like Stevens-Johnson Syndrome.


Q: What is Profemin's safety profile during pregnancy?

A: The official drug label states that animal reproductive studies have suggested potential fetal harm. There are no adequate or well-controlled studies in pregnant women. Furosemide is generally used during pregnancy only if the potential benefit is assessed by a healthcare provider to outweigh the potential risk to the fetus.


Q: Do I need regular blood tests while taking Profemin?

A: Yes, official warnings require frequent monitoring of several laboratory parameters during treatment. These tests are necessary to check levels of serum electrolytes (like potassium), BUN (Blood Urea Nitrogen), creatinine, and uric acid.


Q: Can Profemin affect my blood pressure?

A: Yes. Furosemide is classified as an Antihypertensive Agent and is used to help lower high blood pressure. However, it can also cause hypotension (blood pressure that is too low) as a commonly reported side effect.


Q: What should I tell my dentist or surgeon before a procedure if I'm on Profemin?

A: Official information indicates that Furosemide can affect the activity of certain skeletal muscle relaxing agents used during surgery. It is generally important to inform the surgical team about all medications, including Furosemide, before any elective procedure.


Q: Can Profemin cause changes in vision?

A: Official adverse reaction reports include instances of visual changes. These changes are described as blurred vision and, rarely, xanthopsia (a condition causing objects to appear with a yellowish tint).


Q: What are the general expectations when starting Profemin?

A: The general expectation is a significant increase in urination (diuresis) shortly after administration. Regulatory warnings advise observing for early signs of fluid or electrolyte imbalance, such as increased thirst or dry mouth.


Q: Does Profemin cause dry mouth?

A: Yes, official regulatory documents list dryness of mouth as a possible sign or symptom of fluid or electrolyte imbalance. This is one of the effects that patients receiving Furosemide therapy are advised to watch for.


Q: How does Profemin affect kidney function?

A: While the drug works within the kidney, official warnings note the potential to cause worsening renal function and azotemia (an increase in waste products in the blood). In specific populations like premature infants, there is a documented risk of kidney stone formation.


Q: Are there documented cases of Profemin having no effect on some patients?

A: Regulatory documents acknowledge the risk of developing diuretic resistance, a phenomenon where the diuretic effect of the medicine is reduced or lost. Official information outlines the need for monitoring and potential dose adjustment or combination therapy in case of an inadequate response.


Q: What makes a person ineligible to use Profemin?

A: Official prescribing documents define ineligibility (contraindications) as conditions such as the complete inability to urinate (anuria), a known hypersensitivity to Furosemide, and conditions like hepatic coma or severe electrolyte depletion.


Q: What happens if I stop taking Profemin suddenly?

A: Stopping a treatment for these chronic conditions abruptly could lead to a rebound of fluid retention or an elevation of blood pressure, which may cause symptoms to return.

How should Profemin be stored and disposed of?

How to Store and Dispose of Profemin?

Profemin (Furosemide) must be stored at Controlled Room Temperature, defined as 20 C to 25 C. Excursions are permitted between 15 C and 30 C.

The product must be protected from light and moisture and dispensed in a tight, light-resistant container. It is mandatory to keep this medicine in a closed container and store it out of the reach of children.

Official Storage and Disposal Requirements

Domain Regulatory Requirement
Temperature 20 C to 25 C (Controlled Room Temperature)
Stability Note Oral solution must be discarded 90 days after opening.
Disposal Use a drug take-back program; otherwise, mix with an undesirable substance and seal before discarding in household trash.

Furosemide is not included on the list of medicines recommended for disposal by flushing down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Profemin found in:

A-Z Index: